The global intra-abdominal pressure measurement devices market size is calculated at USD 169.66 million in 2025 and is forecasted to reach around USD 345.99 million by 2034, accelerating at a CAGR of 8.24% from 2025 to 2034. The North America market size surpassed USD 94.04 million in 2024 and is expanding at a CAGR of 8.33% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Intra-Abdominal Pressure Measurement Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Intra-Abdominal Pressure Measurement Devices Market Revenue and Volume Forecast, by Product
8.1.1. Disposables
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Equipment
8.1.2.1. Market Revenue and Volume Forecast
9.1. Intra-Abdominal Pressure Measurement Devices Market Revenue and Volume Forecast, by Procedure
9.1.1. Muscle
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Abdomen
9.1.2.1. Market Revenue and Volume Forecast
10.1. Intra-Abdominal Pressure Measurement Devices Market Revenue and Volume Forecast, by Application
10.1.1. Intra-compartment Pressure
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Intra-abdominal Hypertension
10.1.2.1. Market Revenue and Volume Forecast
11.1. Intra-Abdominal Pressure Measurement Devices Market Revenue and Volume Forecast, by End User
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Clinics
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Trauma Centers
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Ambulatory Surgical Centers (ASCs)
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product
12.1.2. Market Revenue and Volume Forecast, by Procedure
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product
12.1.5.2. Market Revenue and Volume Forecast, by Procedure
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product
12.1.6.2. Market Revenue and Volume Forecast, by Procedure
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product
12.2.2. Market Revenue and Volume Forecast, by Procedure
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product
12.2.5.2. Market Revenue and Volume Forecast, by Procedure
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product
12.2.6.2. Market Revenue and Volume Forecast, by Procedure
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product
12.2.7.2. Market Revenue and Volume Forecast, by Procedure
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product
12.2.8.2. Market Revenue and Volume Forecast, by Procedure
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product
12.3.2. Market Revenue and Volume Forecast, by Procedure
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product
12.3.5.2. Market Revenue and Volume Forecast, by Procedure
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product
12.3.6.2. Market Revenue and Volume Forecast, by Procedure
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product
12.3.7.2. Market Revenue and Volume Forecast, by Procedure
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product
12.3.8.2. Market Revenue and Volume Forecast, by Procedure
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product
12.4.2. Market Revenue and Volume Forecast, by Procedure
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product
12.4.5.2. Market Revenue and Volume Forecast, by Procedure
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product
12.4.6.2. Market Revenue and Volume Forecast, by Procedure
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product
12.4.7.2. Market Revenue and Volume Forecast, by Procedure
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product
12.4.8.2. Market Revenue and Volume Forecast, by Procedure
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product
12.5.2. Market Revenue and Volume Forecast, by Procedure
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product
12.5.5.2. Market Revenue and Volume Forecast, by Procedure
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product
12.5.6.2. Market Revenue and Volume Forecast, by Procedure
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by End User
13.1. Accuryn Medical
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial PerProductance
13.1.4. Recent Initiatives
13.2. Abbott
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial PerProductance
13.2.4. Recent Initiatives
13.3. Biometrix Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerProductance
13.3.4. Recent Initiatives
13.4. BD
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerProductance
13.4.4. Recent Initiatives
13.5. C2DX Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerProductance
13.5.4. Recent Initiatives
13.6. Centurion Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerProductance
13.6.4. Recent Initiatives
13.7. Convatec Group PLC
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerProductance
13.7.4. Recent Initiatives
13.8. Medline Industries, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerProductance
13.8.4. Recent Initiatives
13.9. Gaeltec Devices Ltd.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerProductance
13.9.4. Recent Initiatives
13.10. Spiegelberg GmbH & Co. KG.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerProductance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client